Evidence map›Paper›PMID 36584180›Full record

ArticlePloS one2022

Addressing the quality challenge of a human biospecimen biobank through the creation of a quality management system.

Marie-Dominique Servais, Florence Galtier, Agathe Nouvel, Sandra Rebuffat, Jonas Laget, Anne Géan, Nicolas Provost, Frédéric Lorcy, Valérie Rigau, Guilhem Couderc and 5 more

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marie-Dominique ServaisServier, Suresnes, France.
Florence GaltierINSERM, Clinical Investigation Center 1411, St Eloi Hospital, University Hospital of Montpellier, Montpellier, France.
Agathe NouvelBiocommunication in Cardio-Metabolism (BC2M), University of Montpellier, Montpellier, France.
Sandra RebuffatBiocommunication in Cardio-Metabolism (BC2M), University of Montpellier, Montpellier, France.
Jonas LagetBiocommunication in Cardio-Metabolism (BC2M), University of Montpellier, Montpellier, France.ORCID 0000-0002-9095-7409
Anne GéanServier, Suresnes, France.
Nicolas ProvostServier, Suresnes, France.
Frédéric LorcyBiological Resources Center, Anatomy and Cytology Laboratory, University Hospital of Montpellier, Montpellier, France.
Valérie RigauBiological Resources Center, Anatomy and Cytology Laboratory, University Hospital of Montpellier, Montpellier, France.
Guilhem CoudercBiological Resources Center, Tissue Bank, University Hospital of Montpellier, Montpellier, France.
Philippe GéraudINSERM, Clinical Investigation Center 1411, St Eloi Hospital, University Hospital of Montpellier, Montpellier, France.
David NoccaDepartment of Digestive Surgery, University Hospital of Montpellier, Montpellier, France.
Nicolas BuillesBiological Resources Center, Tissue Bank, University Hospital of Montpellier, Montpellier, France.
Nathalie De PrévilleServier, Suresnes, France.
Anne-Dominique LajoixBiocommunication in Cardio-Metabolism (BC2M), University of Montpellier, Montpellier, France.ORCID 0000-0002-5912-5233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of the COMET (COllection of MEtabolic Tissues) biobank project is to create a high-quality collection of insulin-sensitive tissues (liver, muscle, adipose tissues, and epiploic artery) and blood sample derivatives (plasma, serum, DNA and RNA), collected from 270 grade 2-3 obese patients undergoing bariatric surgery. Relevant data on patient such as clinical/biological characteristics and sample handling are also collected. For this, our aim was to establish a Quality Management System (QMS) to meet the reliability and quality requirements necessary for its scientific exploitation. MATERIALS AND

methodsThe COMET QMS includes: (1) Quality Assurance to standardize all stages of the biobanking process, (2) Quality Controls on samples from the first patients included in order to validate the sample management process and ensure reproducible quality; and 3) "in process" Quality Controls to ensure the reliability of the storage procedures and the stability of the samples over time.

resultsFor serum and plasma, several corrective actions, such as temperature handling and centrifugation conditions, were made to the protocol and led to improvement of the volume and quality of samples. Regarding DNA, all samples evaluated achieved a satisfactory level of purity and integrity and most of them yielded the required DNA quantity. All frozen tissue samples had RNAs of good purity. RNA quality was confirmed by RIN, achieving values in most cases over 7 and efficient amplification of housekeeping genes by RT-qPCR, with no significant differences among samples from the same tissue type. In the "in process" Quality Controls, DNA, RNA, and histological integrity of tissues showed no differences among samples after different preservation times.

conclusionQuality Control results have made it possible to validate the entire biobank process and confirm the utility of implementing QMS to guarantee the quality of a biospecimen collection.

Indexed as

Biological Specimen BanksRNADNAHumansPreservation, BiologicalReproducibility of ResultsSpecimen HandlingDNARNA

Identifiers

PMID36584180
PMCPMC9803146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.